tiprankstipranks
Advertisement
Advertisement

HROW Stock Latest News

Harrow: Operational Stabilization and Retina Growth Support Buy Rating with Unchanged $63 Price Target
RatingsHarrow: Operational Stabilization and Retina Growth Support Buy Rating with Unchanged $63 Price Target
14h ago
HROW
Harrow and Samsung Bioepis present interim BYOOVIZ post-marketing data
PremiumThe Fly
Harrow and Samsung Bioepis present interim BYOOVIZ post-marketing data
2d ago
HROW
Analyst Reaffirms Buy on Harrow Health, Citing Expanding Ophthalmic Franchise and Long-Term Growth Pipeline
PremiumRatings
Analyst Reaffirms Buy on Harrow Health, Citing Expanding Ophthalmic Franchise and Long-Term Growth Pipeline
21d ago
HROW
Harrow announces commercial launch of Byooviz in the U.S.
PremiumThe Fly
Harrow announces commercial launch of Byooviz in the U.S.
21d ago
HROW
Harrow announces commercial launch of BYOOVIZ in U.S.
PremiumThe Fly
Harrow announces commercial launch of BYOOVIZ in U.S.
21d ago
HROW
Harrow Health Stockholders Approve Directors and Executive Pay
PremiumCompany AnnouncementsHarrow Health Stockholders Approve Directors and Executive Pay
30d ago
8K
HROW
Analyst Reiterates Buy on Harrow Health, Citing Verkazia Relaunch and Upcoming Iheezo Data as Key Growth Catalysts
Premium
Ratings
Analyst Reiterates Buy on Harrow Health, Citing Verkazia Relaunch and Upcoming Iheezo Data as Key Growth Catalysts
1M ago
HROW
Harrow Health Releases June 2026 Investor Presentation Update
Premium
Company Announcements
Harrow Health Releases June 2026 Investor Presentation Update
2M ago
8K
HROW
Harrow CEO buys $302K, CFO buys $104.7K in common stock
PremiumThe Fly
Harrow CEO buys $302K, CFO buys $104.7K in common stock
2M ago
HROW
Harrow price target lowered to $60 from $65 at B. Riley
PremiumThe Fly
Harrow price target lowered to $60 from $65 at B. Riley
2M ago
HROW
Harrow price target lowered to $88 from $91 at Cantor Fitzgerald
PremiumThe Fly
Harrow price target lowered to $88 from $91 at Cantor Fitzgerald
2M ago
HROW
Analyst Reiterates Buy Rating and Maintains $63 Price Target as Temporary Headwinds Mask Strengthening Ophthalmic Growth Outlook
PremiumRatings
Analyst Reiterates Buy Rating and Maintains $63 Price Target as Temporary Headwinds Mask Strengthening Ophthalmic Growth Outlook
2M ago
HROW
Harrow Health Earnings Call Highlights Growth Amid Headwinds
PremiumCompany AnnouncementsHarrow Health Earnings Call Highlights Growth Amid Headwinds
2M ago
HROW
Closing Bell Movers: Hims & Hers down 12% on earnings miss
Premium
The Fly
Closing Bell Movers: Hims & Hers down 12% on earnings miss
2M ago
GTM
ASTS
Harrow reports Q1 EPS (74c) vs. (50c) last year
Premium
The Fly
Harrow reports Q1 EPS (74c) vs. (50c) last year
2M ago
HROW
Harrow Highlights Strong VEVYE Demand in Q1 2026
PremiumCompany Announcements
Harrow Highlights Strong VEVYE Demand in Q1 2026
2M ago
8K
HROW
HROW Earnings this Week: How Will it Perform?
PremiumPre-Earnings
HROW Earnings this Week: How Will it Perform?
2M ago
HROW
3 High P/E Stocks with 50%+ Upside Potential in 2026
PremiumMarket News
3 High P/E Stocks with 50%+ Upside Potential in 2026
3M ago
EH
WK
Harrow announces issuance of J-Code for Iopidine 1%
PremiumThe Fly
Harrow announces issuance of J-Code for Iopidine 1%
3M ago
HROW
Harrow selects LogiCare3PL as distribution partner
PremiumThe FlyHarrow selects LogiCare3PL as distribution partner
3M ago
HROW
Harrow management to meet virtually with BTIG
Premium
The Fly
Harrow management to meet virtually with BTIG
3M ago
HROW
Harrow management to meet virtually with BTIG
Premium
The Fly
Harrow management to meet virtually with BTIG
3M ago
HROW

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >